$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Apparatus for tracking moving workpiece by a laser beam 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • B23K-027/00
  • ..FS:
  • 219/121
  • Em
  • 121
  • EB
  • 121
  • LM
  • 121
  • L
  • 68
  • 159
  • 85
  • BA
  • 85
  • BM
  • 384
출원번호 US-0716475 (1976-08-23)
발명자 / 주소
  • Saunders Richard J. (San Jose CA) Mefferd Wayne Sherman (Los Altos Hills CA)
출원인 / 주소
  • Coherent Radiation (Palo Alto CA 02)
인용정보 피인용 횟수 : 394  인용 특허 : 2

초록

Apparatus is disclosed in a system for drilling holes with a laser beam in a plurality of discrete moving workpieces carried by a support which moves each workpiece sequentially along a predetermined path at a predetermined velocity, the apparatus including means for sequentially tracking along a po

대표청구항

A system for drilling holes with a laser beam in a plurality of discrete moving workpieces comprising a support which moves said plurality of discrete workpieces sequentially along a predetermined path at a predetermined velocity, and apparatus for sequentially tracking along a portion of such path

이 특허에 인용된 특허 (2)

  1. Locke Edward V. (Rockport MA), Laser deep cutting process.
  2. Ehlscheid Gunter (Neuwied DT) Langenbeck Peter (Frickingen DT) Stemmler Kurt (Neuwied DT), Method of cutting material to shape from a moving web by burning.

이 특허를 인용한 특허 (394)

  1. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, 8a,14-dihydroxy-7,8-dihydrocodeinone.
  2. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  3. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  4. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  5. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  6. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  14. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  15. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  16. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  17. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  18. Fogel, Barry S.; Kerns, William D.; Fong, Kei-Lai; Chow, San-Laung; Lin, Edward; Wong, David, Acamprosate formulations, methods of using the same, and combinations comprising the same.
  19. Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use.
  20. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  21. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  22. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  23. Zerangue,Noa; Jandeleit,Bernd; Li,Yunxiao; Gallop,Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  24. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  25. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  26. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  27. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  28. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  29. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  30. Gallop,Mark A., Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use.
  31. Gallop, Mark; Cundy, Kenneth C.; Scheuerman, Randall A.; Barrett, Ronald W.; Zerangue, Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  32. Gallop,Mark; Cundy,Kenneth C.; Scheuerman,Randall A.; Barrett,Ronald W.; Zerangue,Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  33. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Annealed coats.
  34. Ayer Atul Devdatt (Palo Alto CA) Ridzon Dana (San Francisco CA), Antidepressive therapy.
  35. Johan H. Geerke ; Keith Perry Minton, Apparatus and methods for alternating laser treatment of pharmaceutical dispensers.
  36. Whitman ; III Hobart A. (Asheville NC), Apparatus for controlled perforation of moving webs with fixed focus laser beam.
  37. Geerke Johan H. (Los Altos CA), Apparatus for forming dispenser delivery ports.
  38. Cashwell Ernest (Richmond VA) Grollimund Everett C. (Midlothian VA) Duley Walter W. (King City VA CAX) Lilly ; Jr. A. Clifton (Richmond VA) Claflin Warren E. (Bon Air VA) Stultz Edward B. (Richmond V, Apparatus for laser perforation of transported articles.
  39. Whitman ; III Hobart A. (Asheville NC), Apparatus for perforating webs with high intensity, coherent radiation.
  40. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Aqueous based pharmaceutical coating composition for dosage forms.
  41. Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Aqueous emulsion for pharmaceutical dosage form.
  42. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  43. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  44. Edelman, Jeffrey L.; Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry; Spada, Lon T.; Blanda, Wendy M., Biodegradable intravitreal tyrosine kinase implants.
  45. Xiang,Jia Ning; Gallop,Mark A.; Cundy,Kenneth C.; Li,Jianhua; Xu,Feng; Zhou,Cindy X.; Bhat,Laxminarayan, Carbidopa prodrugs and derivatives, and compositions and uses thereof.
  46. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  47. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Composition comprising drug, HPC, HPMC and PEO.
  48. Hughes, Patrick M.; Olejnik, Orest; Whitcup, Scott M.; Burke, James A., Compositions and methods for localized therapy of the eye.
  49. Trogden, John T.; Salameh, Adnan K.; Pujara, Chetan P., Compositions and methods for stimulating hair growth.
  50. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  51. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  52. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  53. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  54. Bhatt, Padmanabh; Cruz, Evangeline; Yam, Noymi, Controlled delivery of active agents.
  55. Cruz, Evangeline; Yam, Noymi; Zhong, Adam; Ayer, Atul Devdatt; Bhatt, Padmanabh, Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones.
  56. Miller Ronald Brown,CHX ; Malkowska Sandra Therese Antoinette,GBX ; Wimmer Walter,DEX ; Hahn Udo,DEX ; Leslie Stewart Thomas,GBX ; Smith Kevin John,GBX ; Winkler Horst,DEX ; Prater Derek Allan,GBX, Controlled release formulation.
  57. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  58. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  59. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  60. Oshlack, Benjamin; Huang, Hua Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  61. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  62. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  63. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  64. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  65. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  66. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  67. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  68. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  69. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  70. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  71. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  72. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  73. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  74. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  75. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  76. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  77. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  78. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  79. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  80. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  81. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  82. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  83. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  84. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  85. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  86. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  87. Oshlack, Benjamin; Masselink, John K.; Huang, Hua-Pin; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  88. Patrick S. -L. Wong ; David E. Edgren ; Liang C. Dong ; Crystal Pollock-Dove, Controlled release liquid active agent formulation dosage forms.
  89. Wong, Patrick S. -L.; Edgren, David E.; Dong, Liang C.; Pollock-Dove, Crystal, Controlled release liquid active agent formulation dosage forms.
  90. Cheng, Xiu Xiu; Jan, Steve; Chou, Joseph; Chen, Chih-Ming, Controlled release metformin formulations.
  91. Podhipleux, Nilobon; Cheng, Xiu Xiu; Lodin, Unchalee; Chen, Chih-Ming; Nangia, Avinash; Tian, Dacheng, Controlled release sodium valproate formulation.
  92. Miller Ronald Brown,CHX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Smith Kevin John,GBX ; Wimmer Walter,DEX ; Winkler Horst,DEX ; Hahn Udo,DEX ; Prater Derek Allan,GBX, Controlled release tramadol.
  93. Miller,Ronald Brown; Malkowska,Sandra Therese Antoinette; Wimmer,Walter; Hahn,Udo; Leslie,Stewart Thomas; Smith,Kevin John; Winkler,Horst; Prater,Derek Allan, Controlled release tramadol tramadol formulation.
  94. Wong Vernon G. ; Hu Mae W. L. ; Berger ; Jr. Donald E., Controlled-release biocompatible ocular drug delivery implant devices and methods.
  95. Eckenhoff ; deceased James B. (late of Los Altos CA by Bonnie J. Eckenhoff ; executrix ), Delivery device providing beneficial agent stability.
  96. Eckenhoff James B., Delivery device providing beneficial agent stability.
  97. Ayer Atul D. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA) Wong Patrick S. L. (Palo Alto CA) Hamel Lawrence G. (Sunnyvale CA) Jordan Maureen L. (Mt. View CA), Delivery dispenser for treating cardiac arrhythmias.
  98. Edgren David E. (El Granada CA) Theeuwes Felix (Los Altos CA), Delivery system.
  99. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement.
  100. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Delivery system comprising means for governing fluid into the system and for restricting fluid into the system.
  101. Magruder, Judy A.; Eckenhoff, James B.; Cortese, Richard; Wright, Jeremy C.; Peery, John R., Delivery system comprising two sections for delivering somatotropin.
  102. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Device comprising liner for protecting fluid sensitive medicament.
  103. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Device comprising means for protecting and dispensing fluid sensitive medicament.
  104. Edgren David (El Granada CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA), Device for delivering drug to certain pH environments.
  105. Magruder Judy A. (Mt. View CA) Eckenhoff James B. (Los Altos CA) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (Palo Alto CA), Dispenser for increasing feed conversion of hog.
  106. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Dosage form and method for treating incontinence.
  107. Jao Frank ; Wong Patrick S. -L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Dosage form comprising antiepileptic drug.
  108. Skluzacek, Robert R.; Edgren, David E., Dosage form comprising means for changing drug delivery shape.
  109. Guittard George V. (Cupertino CA) Jao Francisco (San Jose CA) Marks Susan M. (San Jose CA) Kidney David J. (Sunnyvale CA) Gumucio Fernando (Santa Clara CA), Dosage form comprising oxybutynin.
  110. Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Cortese Richard (Cupertino CA), Dosage form for delivering diltiazem.
  111. Ayer, Atul D.; Kuczynski, Anthony L.; Wong, Patrick S., Dosage form for delivering soluble or insoluble drugs.
  112. Magruder Paul R. (Palo Alto CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA), Dosage form for lessening irritation of mocusa.
  113. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  114. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  115. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases.
  116. Ayer Atul D. (Palo Alto CA) Swanson David R. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA), Dosage form for treating cardiovascular diseases comprising isradipine.
  117. Edgren David E. ; Skluzacek Robert R., Dosage form having first and second coats.
  118. Geerke,Johan H., Dosage forms having a barrier layer to laser ablation.
  119. Cruz, Evangeline; Ruhlmann, Gregory; Pollock, Brenda; Li, Sherry; Garcia, Carmelita; Wong, Alfredo M.; Bronz, Ryan; Fink, Tracy; Edgren, David, Drug coating providing high drug loading.
  120. Cruz, Evangeline; Ruhlmann, Gregory; Pollock, Brenda; Li, Sherry; Garcia, Carmelita; Wong, Alfredo M.; Bronz, Ryan; Fink, Tracy; Edgren, David, Drug coating providing high drug loading and methods for providing the same.
  121. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Effective therapy for epilepsies.
  122. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Effective therapy for epilepsies.
  123. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  124. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  125. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  126. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  127. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  128. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  129. Edgren David Emil ; Skluzacek Robert Raymond ; Barclay Brian L. ; Bhatti Gurdish Kaur, Exit means in dosage form.
  130. Edgren David E. ; Li Shu ; Bhatti Gurdish Kaur ; Wong Patrick S. L. ; Skluzacek Robert R., Extended release dosage form.
  131. Edgren, David E.; Wong, Patrick S.-L.; Bhatti, Gurdish K.; Li, Shu; Skluzacek, Robert R., Extended release dosage form.
  132. Jain, Rita I.; Best, Andrea E.; Lockhart, Earle; Marx, Steven E.; Thomas, James W.; Vo, Pamela Giang, Extended release hydrocodone acetaminophen and related methods and uses thereof.
  133. Singh, Aniruddh; Mirmehrabi, Mahmoud, Forms of oxymorphone hydrochloride.
  134. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  135. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  136. Chen, Chih-Ming; Chou, Joseph; Wong, David, HMG-CoA reductase inhibitor extended release formulation.
  137. Magruder Paul R. (Palo Alto CA) Wong Patrick S. (Hayward CA) Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA), Hydrogel formulation for administering non-steroidal drugs.
  138. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related implants.
  139. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  140. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  141. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  142. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  143. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  144. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  145. Hughes, Patrick M., Hypotensive lipid-containing biodegradable intraocular implants and related methods.
  146. Hughes, Patrick M., Hypotensive prostamide-containing biodegradable intraocular implants and related methods.
  147. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  148. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  149. Rodstrom, Theron Robert, Implantable drug delivery system.
  150. Magruder Judy A. (Mt. View CA) Eckenhoff ; deceased James B. (late of Los Altos CA by Bonnie J. Eckenhoff ; executrix ) Cortese Richard (Los Gatos CA) Wright Jeremy C. (Los Altos CA) Peery John R. (S, Implantable system for delivery of fluid-sensitive agents to animals.
  151. Magruder Judy A. ; Eckenhoff ; deceased James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Implantable system for delivery of fluid-sensitive agents to animals.
  152. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  153. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  154. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  155. Wong, Vernon G.; Hu, Mae W. L., Implants and methods for treating inflammation-mediated conditions of the eye.
  156. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michele, Intraocular biodegradable microspheres.
  157. Robinson, Michael R.; Blanda, Wendy M.; Hughes, Patrick M.; Ruiz, Guadalupe; Orilla, Werhner C.; Whitcup, Scott M.; Welty, Devin F.; Lin, Joan-En; Spada, Lon T., Intraocular drug delivery systems.
  158. Hughes, Patrick M., Intraocular pressure reduction with intracameral bimatoprost implants.
  159. Spada, Lon T.; Shiah, Jane Guo; Hughes, Patrick; Malone, Thomas C.; Devries, Gerald W.; Edelman, Jeffrey L.; Wurster, Julie A.; Guo, Xialing; Boral, Sougato, Kinase inhibitors.
  160. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Lamina comprising carboxyvinyl polymer.
  161. Ma Kong (Duluth GA) Pinder John T. (Marietta GA), Laser drilling of components.
  162. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  163. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  164. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  165. Corfe Arthur G. (Bristol GB2) Stroud David (Bristol GB2) Towill Jonathan P. W. (Cardiff GB7), Method and apparatus for drilling a shaped hole in a workpiece.
  166. Geerke Johan H. (Los Altos CA), Method and apparatus for forming dispenser delivery ports.
  167. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  168. Lilly ; Jr. A. Clifton (Richmond VA) Claflin Warren E. (Bon Air VA) Stultz Edward B. (Richmond VA) Brooks Ulysses A. (Glen Allen VA) Martin Peter (Richmond VA), Method and system for laser perforation of sheet material.
  169. Ayer Atul Devdatt ; Ridzon Dana A., Method for administering tandospirone.
  170. Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Cortese Richard (Cupertino CA), Method for delivering dosage form for diltiazem.
  171. Eckenhoff James B. (Los Altos CA) Magruder Judy A. (Mt. View CA) Cortese Richard (Cupertino CA) Peery John R. (Palo Alto CA) Wright Jeremy C. (Los Altos CA), Method for delivering somatotropin to an animal.
  172. Anthony L. Kuczynski ; Atul Devolatt Ayer ; Patrick S. L. Wong, Method for lowering blood glucose.
  173. Kuczynski Anthony L. (Mountain View CA) Ayer Atul D. (Palo Alto CA) Wong Patrick S.-L. (Palo Alto CA), Method for lowering blood glucose.
  174. Kuczynski, Anthony L.; Ayer, Atul Devdatt; Wong, Patrick S. L., Method for lowering blood glucose.
  175. Dung, Jen-Sen; Keskeny, Erno M.; Mencel, James J., Method for making analgesics.
  176. Ayer Atul Devatt ; Yieh Richard L.-C. ; Pollock Brenda J. ; Wong Patrick S.-L., Method for providing sustained antiepileptic therapy.
  177. Wong, Vernon G, Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  178. Wong, Vernon G., Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  179. Wong, Vernon G., Method for reducing transplant rejection in the eye and intraocular implants for use therefor.
  180. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Method for the management of incontinence.
  181. Guittard, George V.; Jao, Francisco; Marks, Susan M.; Kidney, David J.; Gumucio, Fernando E., Method for the management of incontinence.
  182. Jao Frank ; Wong Patrick S.-L. ; Cruz Evangeline ; Sy Eduardo C. ; Kuczynski Anthony L., Method for treating epilepsies.
  183. David Emil Edgren ; Gurdish Kaur Bhatti ; Zahedeh Hatamkhani ; Patrick S. L. Wong, Method of administering antidepressant dosage form.
  184. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid.
  185. Hughes, Patrick M.; Sarrazin, Christian; Rossi, Elisabeth; Boix, Michèle, Method of making tyrosine kinase microspheres.
  186. Sackler Richard ; Kaiko Robert ; Goldenheim Paul, Method of treating humans with opioid formulations having extended controlled release.
  187. Sackler, Richard; Kaiko, Robert; Goldenheim, Paul, Method of treating humans with opioid formulations having extended controlled release.
  188. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  189. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  190. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  191. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar, Methods and devices for providing prolonged drug therapy.
  192. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G., Methods and devices for providing prolonged drug therapy.
  193. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
  194. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D., Methods and devices for providing prolonged drug therapy.
  195. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  196. Wong, Vernon G., Methods for reducing edema.
  197. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use.
  198. Wong, Vernon G, Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  199. Wong, Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  200. Wong,Vernon G., Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor.
  201. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  202. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  203. Cheng, Xiu Xiu; Chen, Chih-Ming; Jan, Steve; Chou, Joseph, Methods for treating diabetes via administration of controlled release metformin.
  204. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  205. Wong, Vernon G., Methods for treating edema in the eye and intraocular implants for use therefor.
  206. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  207. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  208. Whitcup, Scott M.; Weber, David A., Methods for treating retinopathy with extended therapeutic effect.
  209. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  210. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  211. Guido, Debora; Huang, Haiyong Hugh, Methods of preparing tamper resistant pharmaceutical formulations.
  212. Sackler, Richard S., Methods of preparing tamper resistant solid oral dosage forms.
  213. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  214. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  215. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Methods of treating ocular disease using steroid-containing sustained release intraocular implants.
  216. Amick, David R., Microbiocidal article for aqueous systems.
  217. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Microparticles manufactured in an oil-in-water process comprising a prostamide.
  218. Weyers Richard G. ; Ayer Atul D. ; Pollock Brenda J. ; Barclay Brian L. ; Quan Ernest S., Nutritional support system.
  219. Weyers Richard G. ; Ayer Atul D. ; Pollock Brenda J. ; Barclay Brian L. ; Quan Ernest S., Nutritional support system.
  220. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  221. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  222. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  223. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  224. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  225. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  226. Shiah, Jane-Guo; Bhagat, Rahul; Blanda, Wendy M.; Nivaggioli, Thierry; Peng, Lin; Chou, David; Weber, David A., Ocular implant made by a double extrusion process.
  227. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide.
  228. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  229. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  230. Hughes, Patrick M.; Boix, Michele; Sarrazin, Christian; Do, Marina, Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods.
  231. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  232. Chang, James; Hughes, Patrick; Chang, Chin-Ming, Oil-in-water method for making polymeric implants containing a hypotensive lipid.
  233. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opiod agonist formulations with releasable and sequestered antagonist.
  234. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist / antagonist combinations.
  235. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  236. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  237. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  238. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  239. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  240. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  241. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  242. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  243. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist/antagonist combinations.
  244. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  245. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  246. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  247. Wimmer, Walter; Brogmann, Bianca; Hahn, Udo; Spitzley, Christof, Opioid analgesic.
  248. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled release.
  249. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  250. Chao Shouchung,TWX ; Tseng Wen-Pao,TWX ; Chang Hui-Fang,TWX ; Chen David,TWX ; Lu Shu-Bin,TWX, Oral cisapride dosage forms with an extended duration.
  251. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  252. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  253. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  254. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  255. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  256. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  257. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  258. Kuczynski Anthony L. (Palo Alto CA) Ayer Atul D. (Palo Alto CA) Wong Patrick S.-L. (Palo Alto CA), Oral hypoglycemic glipizide granulation.
  259. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharamaceutical dosage forms.
  260. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  261. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  262. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  263. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  264. Cundy, Kenneth C.; Gallop, Mark A., Orally administered dosage forms of GABA analog prodrugs having reduced toxicity.
  265. Ayer Atul D. (Mt. View CA), Osmotic device with inert core.
  266. Wong Patrick S.-L. (Hayward CA) Barclay Brian L. (Sunnyvale CA) Oeters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA), Osmotic system comprising plurality of members for dispensing drug.
  267. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R. ; Pike James B. ; Robinson Urano A. ; Smith Jonathan P. ; Ziemann Lyle E., Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals.
  268. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Oxybutynin therapy.
  269. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone compositions.
  270. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone.
  271. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone.
  272. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  273. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  274. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  275. Lyons, Robert T.; Robinson, Michael R.; Trogden, John T.; Whitcup, Scott M., Peripherally administered viscous formulations.
  276. Whitcup, Scott M.; Robinson, Michael R.; Lyons, Robert T.; Trogden, John T., Peripherally administered viscous formulations.
  277. Edgren,David E.; Li,Shu; Wong,Patrick S. L.; Bhatti,Gurdish; Dong,Liang Chang; Yum,Si Hong, Pharmaceutical coating composition and method of use.
  278. Edgren,David E.; Li,Shu; Wong,Patrick S. L.; Bhatti,Gurdish; Dong,Liang Chang; Yum,Si Hong, Pharmaceutical coating composition and method of use.
  279. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  280. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  281. Leslie Stewart Thomas,GBX ; Knott Trevor John,GBX ; Mohammad Hasssan,GBX ; Prater Derek Allan,GBX, Pharmaceutical composition containing a fusible carrier and method for producing the same.
  282. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical composition containing gelling agent.
  283. Lyons, Robert T.; Chang, James N.; Trogden, John T.; Whitcup, Scott, Pharmaceutical compositions.
  284. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  285. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  286. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  287. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  288. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  289. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  290. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  291. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  292. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  293. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  294. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  295. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  296. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  297. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  298. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  299. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  300. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  301. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  302. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  303. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  304. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  305. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  306. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  307. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  308. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  309. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  310. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  311. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  312. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  313. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  314. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  315. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  316. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  317. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  318. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  319. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  320. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  321. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical product comprising a sequestered agent.
  322. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical products.
  323. Shivanand Padmaja ; Hatamkhany Zahedeh ; Laidlaw Barbara F. ; Ayer Atul D., Phenytoin therapy.
  324. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  325. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  326. Magruder Judy A. ; Eckenhoff James B. ; Cortese Richard ; Wright Jeremy C. ; Peery John R., Polyurethane-containing delivery systems.
  327. Oshlack Benjamin ; Pedi Frank, Powder-layered oral dosage forms.
  328. Assa, Shlomo; Meyer, Steven Jerome; Rideout, Jeffrey Allen, Printing a code on a product.
  329. Assa, Shlomo; Meyer, Steven Jerome; Rideout, Jeffrey Allen, Printing a code on a product.
  330. Assa,Shlomo; Meyer,Steven Jerome; Rideout,Jeffrey Allen, Printing a code on a product.
  331. Gebbie, Stuart James; Giguere, Joshua R.; McCarthy, Keith; Rider, Lonn S., Process for improved opioid synthesis.
  332. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxycodone synthesis.
  333. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxymorphone synthesis.
  334. Giguere, Joshua Robert; McCarthy, Keith Edward; Schleusner, Marcel, Process for improved oxymorphone synthesis.
  335. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Process for preparing oxycodone compositions.
  336. Chapman, Robert; Rider, Lonn S.; Hong, Qi; Kyle, Donald; Kupper, Robert, Process for preparing oxycodone compositions.
  337. Chapman,Robert; Rider,Lonn S.; Hong,Qi; Kyle,Donald; Kupper,Robert, Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone.
  338. Wright Jeri D. (Dublin CA) Barclay Brian L. (Sunnyvale CA) Atkinson Linda E. (Portola Valley CA), Process for providing therapeutic composition.
  339. Grant, Ewart; Heinrich, Brian; Matharu, Saroop; Archer, Nicolas, Process for the preparation of oxymorphone alkaloid and oxymorphone salts.
  340. Matharu, Saroop; Heinrich, Brian; Singh, Aniruddh; Mirmehrabi, Mahmoud, Process of preparing low ABUK oxymorphone hydrochloride.
  341. Gallop, Mark A., Prodrugs of gaba analogs, compositions and uses thereof.
  342. Dong Liang C. (Mountain View CA) Wong Patrick S.-L. (Palo Alto CA) Espinal Steven (Sunnyvale CA), Progesterone replacement therapy.
  343. Dong Liang C. ; Wong Patrick S. L. ; Espinal Steven, Progesterone replacement therapy.
  344. Dong Liang C. (Mountain View CA) Wong Patrick S.-L. (Palo Alto CA) Espinal Steven (Sunnyvale CA), Progestin tablet.
  345. Amick David R. (Chalfont PA), Protracted release microbiocidal article for aqueous systems.
  346. Hamel Larry G. (Sunnyvale CA) Landrau Felix A. (Milpitas CA) Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA), Pseudoephedrine dosage form.
  347. Assa,Shlomo; Meyer,Steven; Rapposelli,Mark; Stine,John F., Pulsed laser printing.
  348. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  349. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  350. Boehm, Garth, Sequestering subunit and related compositions and methods.
  351. Boehm, Garth, Sequestering subunit and related compositions and methods.
  352. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  353. Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M; Chang, James N.; Olejnik, Orest, Steroid-containing sustained release intraocular implants and related methods.
  354. Robinson, Michael R.; Whitcup, Scott M., Steroid-containing sustained release intraocular implants and related methods.
  355. Franklin,Kevin; Derkalousdian,Moses; Meyer,Steve, Striping and clipping correction.
  356. Ayer Atul Devatt ; Yien Richard L.-C. ; Pollock Brenda J. ; Wong Patrick S.-L., Sustained antiepileptic therapy.
  357. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  358. Shiah, Jane-Guo; Pujara, Chetan, Sustained drug delivery implant.
  359. Heafield Joanne,GBX ; Knott Trevor John,GBX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Miller Ronald Brown,CHX ; Prater Derek Allan,GBX ; Smith Kevin John,GBX, Sustained release compositions and a method of preparing pharmaceutical compositions.
  360. Heafield Joanne,GB2 ; Knott Trevor John,GB2 ; Leslie Stewart Thomas,GB2 ; Malkowska Sandra Therese Antoinette,GB2 ; Miller Ronald Brown,CHX ; Prater Derek Allan,GB2 ; Smith Kevin John,GB2, Sustained release compositions of morphine and a method of preparing pharmaceutical compositions.
  361. Qiu, Yihong; Klein, Cheri E, Sustained release formulations of opioid and nonopioid analgesics.
  362. Burke, James; Hughes, Patrick M.; Werhner, Orilla C.; Lin, Ton C.; Escobar, Maria; Huang, Glenn; Zhang, Kai-Ming; Wheeler, Larry A.; Donn, Rosy S., Sustained release intraocular implants and methods for preventing retinal dysfunction.
  363. Huang, Glenn T.; Burke, James A.; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Sheng, Rosy, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  364. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  365. Huang, Glenn T.; Burke, James; Hughes, Patrick M.; Zhang, Kai-Ming; Lin, Ton; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for preventing retinal dysfunction.
  366. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and methods for treating ocular neuropathies.
  367. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  368. Huang, Glenn T.; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  369. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  370. Huang, Glenn T; Jackson, Brittany; Burke, James A.; Lin, Ton; Hughes, Patrick M.; Wheeler, Larry A.; Donn, Rosy Sheng, Sustained release intraocular implants and methods for treating ocular vasculopathies.
  371. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  372. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  373. Huang, Glenn T.; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  374. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  375. Huang, Glenn T; Nivaggioli, Thierry, Sustained release intraocular implants and related methods.
  376. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  377. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffery L.; Chang-Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  378. Hughes, Patrick M.; Malone, Thomas C.; De Vries, Gerald W.; Edelman, Jeffrey L.; Chang-Lin, Joan-En; Shiah, Jane Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  379. Hughes, Patrick M.; Malone, Thomas C.; DeVries, Gerald W.; Edelman, Jeffrey L.; Lin, Joan-En; Shiah, Jane-Guo; Nivaggioli, Thierry, Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods.
  380. Pope Peter J. (Balcombe GB2) Willis-Owen Richard B. (Horsham GB2), Synchronous arrangement and method for heat treating workpieces.
  381. Guittard George V. (Cupertino CA) Childers Jerry D. (Menlo Park CA) Wong Patrick S. -L. (Palo Alto CA) Gumucio Fernando E. (Santa Clara CA) Kidney David J. (Sunnyvale CA), Tacrine therapy.
  382. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  383. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  384. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  385. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  386. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  387. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  388. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  389. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  390. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  391. Guittard George V. ; Childers Jerry D. ; Wong Patrick S.-L. ; Gumucio Fernando E. ; Kidney David J., Therapy for neurological diseases.
  392. Barrett, Ronald W.; Canafax, Daniel M., Treating or preventing restless legs syndrome using prodrugs of GABA analogs.
  393. Barrett, Ronald W., Treating urinary incontinence using prodrugs of GABA analogs.
  394. Hu, Zhaoli; Huang, Chunfu Cliff, Variable focus laser machining system.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로